(Fighting against New Coronary Pneumonia) National Medical Insurance Administration: China's first domestically produced new crown oral drug can be temporarily included in medical insurance reimbursement
China News Agency, Beijing, August 12. According to Chinese official media on the 12th: The reporter learned from the National Medical Security Administration of China that in accordance with the relevant provisions of basic medical insurance, in order to better meet the needs of diagnosis and treatment, all drugs included in the diagnosis and treatment plan of new coronary pneumonia , can be temporarily included in the scope of medical insurance payment.
On August 9, the National Health Commission of China has issued a notice to include Azvudine Tablets in the new coronavirus pneumonia diagnosis and treatment plan, so the medical insurance fund can be paid according to regulations when insured patients use the drug.
(Finish)